ICU Medical (ICUI) Tops Q4 EPS by 4c; Offers FY23 EPS Guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.60, $0.04 better than the analyst estimate of $1.56. Revenue for the quarter came in at $578 million versus the consensus estimate of $578.77 million.

GUIDANCE:

ICU Medical sees FY2023 EPS of $5.75-$7.25, versus the consensus of $7.22.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral
• Pfizer reaffirms 2026 guidance after CFO transition news